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Abstract. Beneficial effect on the DIEE bio-phyto-modulator was highlighted by several 
studies in recent years. The purpose is to study the effect of therapy with DEA and DIEE for patients 
with different localization of polycystic disease. 
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INTRODUCTION 
 
 
  Beneficial effect on the DIEE bio-phyto-modulator was highlighted by several studies 
in recent years. The purpose of this paper is to study the effect of therapy with DEA and DIEE 
for patients with different localization of polycystic disease (Dincă, 2005; Dincă, 2010 ). 
             It was a prospective study that followed for one year evolution of a group of patients 
with polycystic disease. Patients were included in the period 01.2009-06.2011; Patients were 
followed for treatment to Medicali’s Clinic in Timisoara. 
            
MATERIALS AND METHODS 
  
  It were studied a total of 110 patients who were diagnosed with the following diseases: 
a) Breast cysts 33 patients, 
b) Thyroid cysts12 patients, 
c) Ovarian cysts 40 patients, 
d) Renal cysts 22 patients, 
e) Synovial cysts 5 patients. 
             The diagnosis was based on the principles of allopathic medicine, using high imaging 
methods: 
a) For breast cysts, from 33 patients, females, 12 had confirmation of the diagnosis by 
mammography and all 33 had breast ultrasound performed to confirm diagnosis. These 
investigations were carried out in accredited medical centers;  
b) Thyroid cysts were diagnosed only by thyroid ultrasound. For these patients, females, was 
evaluated thyroid function and thyroid hormone dosage;  
c) Ovarian cysts were diagnosed by gynecological clinical exam and transvaginal or 
abdominal ultrasound;  
d) Renal cysts were followed with abdominal ultrasound;  
e) Synovial cysts were followed by computed tomography or magnetic resonance. 
   
I mention that all patients from study were presented with well documented diagnosis 
by the methods mentioned above.  
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            Treatment method consist of application on the body of AD bio-phyto-modulators as 
follows: 
a) for mammary cysts one DEA, separately, and two DIEE bio-phyto-modulators on each 
breast; 
b) for thyroid cysts one DEA, separately, and three DIEE bio-phyto-modulators on the two 
lobes of thyroid and one on the sternum;  
c) For ovarian cysts were used one DEA, separately, and two DIEE bio-fito-modulators on 
each ovary;  
d) For renal cysts one DEA, separately, and three DIEE bio-phyto-modulators on the two 
kidney thyroid and one on the sternum;  
e) For synovial cysts one DEA, separately, and three DIEE bio-phyto-modulators on the 
extremities of cyst and one on the sternum. 
             Tracking patients was performed by successive review to 2, 6 and 12 months after 
beginning of the treatment. During these visits it was verified: cysts size evolution by the 
same methods as the first visit; appreciation of general state of the body; health assessment. 
 
RESULTS AND DISCUSSION 
 
  1. Patients with breast cysts. From 33 patients with breast cysts, 21 patients were 
presented to all controls, including control of one year after beginning treatment. The results 
show a general improvement of health in all patients. Dimensions of cysts were between 
10mm and 34mm at diagnosis, with an average of 23 mm. After 2 months cysts size was 
reduced to an average of 19.7mm and 12mm at 6 months. The final assessment 1 year after 
start of treatment showed results from 6 months to maintain and even further reduce the 
minimum, but without statistical significance.
 
  2. Patients with thyroid cysts. From 12 patients, 4 had cystic determinations on both 
thyroid lobes, and 8 patients on one lobe. Thyroid function was altered in case of eight 
patients: 6 patients with hypothyroidism and 2 patients with hyperthyroidism. From this study 
group 4 patients were euthyroiditis. Thyroid cysts size was between 4mm and 30mm with an 
average of 17.4 mm. After 2 months of treatment it decreased the average size with 9.4 mm, 
to 8mm respectively. Note that 4 patients’ cysts disappeared completely in 2 months. Also 
thyroid function was normalized in 5 from 8 patients with thyroid dysfunction. 
Assessment at 6 months showed an average diameter of 6.2 mm of thyroid cysts therefore a 
further important reduction and evaluation of one year showed an average size of 3.9 mm. 
  3. Patients with ovarian cysts. At baseline, 15 patients were diagnosed with bilateral 
cystic disease, and 25 of the group had unilateral involvement. The maximum size of cysts 
was 65mm and the average of 37.8 mm. Evaluation after 2 months occurred in case of 36 
patients who had a reduction in menstrual disorders, general condition improved and a 
reduction in the average size of cysts at 28.1mm. At 6 months assessment showed a mean 
reduction of 21.9 mm cysts, and at 12 months to 18.9 mm. 
  4. Patients with renal cysts. 5 of the 22 patients with renal cysts were revealed bilateral 
involvement and 17 patients unilateral damage. The maximum size of cysts was 65mm and 
the average values of cysts diameter was 47.56 mm. Assessment after 2 months was 
performed in case of 17 patients and showed a diameter of 44.78 mm, so a small reduction. 
At 6 months assessment In case of 15 patients showed an average diameter of 26.56 mm, so a 
significant reduction. At 12 months there had only 9 patients, which have made difficult 
interpretation of results as 21.2mm. 
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  5. Patients with synovial cysts. The 5 patients had cysts of the following places: 2 - 
ankle’s cyst, 2 - synovial cyst in the popliteal space, 1 - cyst at the elbow joint. 
From 5 patients for 3 of them cyst size decreased in 2 months and for 1 patient the cyst had 
disappeared completely. 1 patient has not come to scheduled visits. 
 
CONCLUSIONS 
  
  AD bio-phyto-modulators are useful in the treatment of cystic formations in various 
locations. 
  Using complementary methods should be mandatory in this type of disease to 
minimize surgical trauma. 
  If breast cysts and thyroid cysts size reduction is much faster, the duration of therapy 
must remain for 12 months to strengthen the results. 
  In case of thyroid it is observed a normalization of thyroid function in many patients. 
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